KMC Speciality Hospitals (India) Ltd
Incorporated in 1982, KMC Speciality Hospitals (India) is in the healthcare sector running, operating, maintaining multi-specialty hospital in Trichy. The company belongs to the Kauvery Hospitals group. The Company is primarily engaged in the business of rendering medical and healthcare services.
- Market Cap ₹ 1,011 Cr.
- Current Price ₹ 62.0
- High / Low ₹ 73.0 / 50.0
- Stock P/E 37.9
- Book Value ₹ 6.96
- Dividend Yield 0.00 %
- ROCE 26.4 %
- ROE 26.6 %
- Face Value ₹ 1.00
Pros
- Company has delivered good profit growth of 31.8% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 27.2%
- Company's median sales growth is 16.4% of last 10 years
Cons
- Stock is trading at 8.91 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
20 | 29 | 32 | 36 | 43 | 55 | 71 | 82 | 96 | 103 | 136 | 156 | |
16 | 23 | 30 | 31 | 35 | 42 | 56 | 66 | 75 | 79 | 99 | 114 | |
Operating Profit | 3 | 6 | 2 | 6 | 8 | 12 | 14 | 16 | 21 | 23 | 37 | 41 |
OPM % | 17% | 21% | 5% | 16% | 19% | 23% | 20% | 20% | 22% | 23% | 28% | 27% |
0 | 0 | 3 | 0 | 1 | 0 | 0 | 2 | 1 | 2 | 2 | 3 | |
Interest | 1 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Depreciation | 1 | 1 | 4 | 4 | 3 | 3 | 4 | 4 | 5 | 6 | 7 | 8 |
Profit before tax | 1 | 1 | -2 | 0 | 4 | 8 | 10 | 12 | 17 | 18 | 32 | 36 |
Tax % | 35% | 32% | 81% | 0% | 21% | 33% | 32% | 30% | 30% | 29% | 26% | 26% |
Net Profit | 1 | 1 | -0 | 0 | 3 | 5 | 7 | 9 | 12 | 13 | 24 | 27 |
EPS in Rs | 0.05 | 0.06 | -0.02 | 0.01 | 0.20 | 0.33 | 0.41 | 0.53 | 0.72 | 0.78 | 1.46 | 1.64 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 18% |
5 Years: | 17% |
3 Years: | 17% |
TTM: | 14% |
Compounded Profit Growth | |
---|---|
10 Years: | 36% |
5 Years: | 32% |
3 Years: | 31% |
TTM: | 13% |
Stock Price CAGR | |
---|---|
10 Years: | 42% |
5 Years: | 28% |
3 Years: | 58% |
1 Year: | 10% |
Return on Equity | |
---|---|
10 Years: | 25% |
5 Years: | 27% |
3 Years: | 27% |
Last Year: | 27% |
Balance Sheet
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | |
Reserves | -4 | -3 | -6 | -6 | -3 | 8 | 14 | 23 | 34 | 47 | 70 | 97 |
15 | 16 | 16 | 14 | 10 | 6 | 15 | 10 | 9 | 29 | 29 | 50 | |
3 | 5 | 7 | 7 | 6 | 8 | 8 | 10 | 11 | 13 | 13 | 18 | |
Total Liabilities | 31 | 34 | 33 | 31 | 29 | 38 | 53 | 60 | 70 | 105 | 129 | 182 |
23 | 29 | 28 | 25 | 23 | 24 | 37 | 36 | 39 | 74 | 75 | 84 | |
CWIP | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 6 | 34 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
7 | 4 | 5 | 6 | 7 | 14 | 16 | 24 | 31 | 29 | 48 | 63 | |
Total Assets | 31 | 34 | 33 | 31 | 29 | 38 | 53 | 60 | 70 | 105 | 129 | 182 |
Cash Flows
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
4 | 7 | 4 | 5 | 6 | 10 | 12 | 16 | 11 | 26 | 29 | ||
-8 | -7 | -2 | -1 | -1 | -4 | -19 | -9 | -8 | -43 | -29 | ||
4 | -3 | -1 | -5 | -5 | -5 | 6 | -5 | -4 | 18 | -1 | ||
Net Cash Flow | -0 | -3 | 0 | -0 | -0 | 1 | -1 | 1 | -1 | 1 | -0 |
Ratios
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 19 | 17 | 11 | 12 | 13 | 12 | 13 | 8 | 8 | 9 | 10 | 10 |
Inventory Days | 76 | 58 | 48 | 42 | 32 | 28 | 24 | 29 | 59 | 39 | 33 | 36 |
Days Payable | 106 | 129 | 187 | 169 | 158 | 134 | 143 | 161 | 115 | 117 | 96 | 102 |
Cash Conversion Cycle | -11 | -53 | -129 | -115 | -112 | -94 | -107 | -125 | -48 | -68 | -53 | -56 |
Working Capital Days | -6 | -27 | -70 | -61 | -50 | -46 | -33 | -28 | -17 | -9 | -7 | -9 |
ROCE % | 11% | 19% | 2% | 8% | 24% | 35% | 29% | 29% | 33% | 25% | 32% | 26% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
10h - Copies of extract of the Audited Standalone Financial Results of the Company for the quarter and year ended March 31, 2023 (AFR) published on May …
-
Disclosure Under Regulation 23(9) Of The SEBI (LODR) Regulations, 2015
10h - Statement on related party transactions of the Company for the half-year ended March 31, 2023.
- Audited Financial Results For The Quarter And Year Ended 31St March, 2023 Along With The Auditors Report. 1d
- Board Meeting Outcome for Board Meeting Outcome For Outcome Of Board Meeting Held On 29Th May, 2023 1d
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 26 May
Annual reports
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Services Provided:[1]
The company runs a 227 bed multi-specialty hospital at Trichy, Tamil Nadu. It offers services in neurology, nephrology, obstetrics, gynecology, pediatrics, neonatology, cardiology, ENT, dental, orthopedics, joint replacement, liver transplant surgery, neurosurgery, plastic surgery, etc.